Literature DB >> 26705409

Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.

Rachael A Vaubel1, Selby G Chen1, David R Raleigh1, Michael J Link1, Michael R Chicoine1, Igor Barani1, Sarah M Jenkins1, Patrice Abell Aleff1, Fausto J Rodriguez1, Peter C Burger1, Sonika Dahiya1, Arie Perry1, Caterina Giannini2.   

Abstract

The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n = 22, 50%) or II (n = 22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p = 0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.
© 2015 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Anaplastic meningioma; Meningioma; Rhabdoid meningioma; WHO grade

Mesh:

Year:  2015        PMID: 26705409      PMCID: PMC5009417          DOI: 10.1093/jnen/nlv006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  51 in total

1.  Rhabdoid meningioma occurring in an unrelated resection cavity with leptomeningeal carcinomatosis. Case report.

Authors:  Marthew A Koenig; Romergryko G Geocadin; Piotr Kulesza; Alessandro Olivi; Henry Brem
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

2.  Rhabdoid cystic papillary meningioma with diffuse subarachnoid dissemination.

Authors:  Koichi Wakabayashi; Naoya Suzuki; Fumiaki Mori; Mitsuru Kamada; Mitsuaki Hatanaka
Journal:  Acta Neuropathol       Date:  2005-06-25       Impact factor: 17.088

3.  Rhabdoid meningioma: rapid intraoperative diagnosis on squash smears.

Authors:  M Bansal; V P Pathak; S Kishore; K K Bansal
Journal:  Diagn Cytopathol       Date:  2010-08       Impact factor: 1.582

4.  Intraspinal rhabdoid meningioma metastasis to the liver.

Authors:  Zhaoming Wang; Mei Kong; Jun Li; Wenbo Xiao; Shusen Zheng
Journal:  J Clin Neurosci       Date:  2011-02-23       Impact factor: 1.961

5.  Necrotic rhabdoid meningiomas with aggressive clinical behavior.

Authors:  E Matyja; W Grajkowska; P Nauman; W Bonicki; P Bojarski; A Marchel
Journal:  Clin Neuropathol       Date:  2010 Sep-Oct       Impact factor: 1.368

6.  Differential expression of extracellular matrix-related genes in rare variants of meningioma.

Authors:  Mi Jung Kwon; Chang Ohk Sung; So Young Kang; In-Gu Do; Yeon-Lim Suh
Journal:  Hum Pathol       Date:  2012-09-17       Impact factor: 3.466

7.  June 2004: a male in his late 60s with recurrent extracerebral tumor.

Authors:  Christian Mawrin; Rainer Hahne; Cordula Scherlach; Elmar Kirches; Knut Dietzmann
Journal:  Brain Pathol       Date:  2004-10       Impact factor: 6.508

8.  Intracerebral cystic rhabdoid meningioma.

Authors:  Debnarayan Dutta; Hsueh Ni Lee; Anusheel Munshi; Tejpal Gupta; Subhada Kane; Epari Sridhar; Rakesh Jalali
Journal:  J Clin Neurosci       Date:  2009-05-08       Impact factor: 1.961

9.  Unusual growth pattern of a meningioma.

Authors:  Hiroshi Kashimura; Tomohiko Mase; Kuniaki Ogasawara; Akira Kurose
Journal:  Surg Neurol Int       Date:  2012-06-09

10.  Metastatic rhabdoid meningioma of the parotid - Mimicking primary salivary gland neoplasm.

Authors:  Rajesh Parameshwaran Nair; Yashdeep Sarma; Bhavna Nayal; Sumeet Kaur Dil; Pradeep Kumar Tripathi
Journal:  Int J Surg Case Rep       Date:  2014-12-03
View more
  19 in total

Review 1.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

2.  De novo and secondary anaplastic meningiomas: natural history, prognosis, and the TERT promoter.

Authors:  Brett J Theeler
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

Review 3.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 4.  BAP1 mutations in high-grade meningioma: implications for patient care.

Authors:  Ganesh M Shankar; Sandro Santagata
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

5.  Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma.

Authors:  M Adelita Vizcaino; Caterina Giannini; Howard T Chang; Benjamin R Kipp; Karen Fritchie; Rachael Vaubel
Journal:  Brain Tumor Pathol       Date:  2021-01-12       Impact factor: 3.298

6.  Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.

Authors:  Ganesh M Shankar; Malak Abedalthagafi; Rachael A Vaubel; Parker H Merrill; Naema Nayyar; Corey M Gill; Ryan Brewster; Wenya Linda Bi; Pankaj K Agarwalla; Aaron R Thorner; David A Reardon; Ossama Al-Mefty; Patrick Y Wen; Brian M Alexander; Paul van Hummelen; Tracy T Batchelor; Keith L Ligon; Azra H Ligon; Matthew Meyerson; Ian F Dunn; Rameen Beroukhim; David N Louis; Arie Perry; Scott L Carter; Caterina Giannini; William T Curry; Daniel P Cahill; Frederick G Barker; Priscilla K Brastianos; Sandro Santagata
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

7.  Pediatric meningioma with rhabdoid features developed at the site of skull fracture: illustrative case.

Authors:  Sho Takata; Akira Tamase; Yasuhiko Hayashi; Osamu Tachibana; Katsuaki Sato; Hideaki Iizuka
Journal:  J Neurosurg Case Lessons       Date:  2021-10-04

8.  De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.

Authors:  Matthieu Peyre; Guillaume Gauchotte; Marine Giry; Sébastien Froehlich; Johan Pallud; Thomas Graillon; Franck Bielle; Dominique Cazals-Hatem; Pascale Varlet; Dominique Figarella-Branger; Hugues Loiseau; Michel Kalamarides
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

9.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

Review 10.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.